Rick Mullin

发表

Rick Mullin, 2004 .

Rick Mullin, 2005 .

ASTELLAS PRESSES BID FOR OSI: PHARMACEUTICALS: Japanese firm hopes to add oncology to its U.S. operations

Rick Mullin, 2010 .

PERSONALIZED MEDICINE: Armed with the decoded human genome, drug researchers and clinicians are working to close the gap between PATIENT AND THERAPY

Rick Mullin, 2008 .

PRIMING THE PIPELINE

Rick Mullin, R. Mullin, 2004 .

INSIGHTS: AMATEURS ATTACK

Rick Mullin, 2003 .

Lonza buys sterile plant from Novartis

Rick Mullin, 2019 .

CUSTOM PRODUCERS END DIFFICULT YEAR: Pharmaceutical ingredient makers look for renewed interest in 2005

Ann Thayer, Rick Mullin, 2004 .

AKZO ADVANCES WITH PFIZER PACT: Partnership cements commitment to the pharma sector

Rick Mullin, 2003 .

INFORMATION TECHNOLOGY: Chemical producers weigh targeted system upgrades in a new, Internet-driven world of choices

Rick Mullin, 2005 .

RECLAIM THE COMMONS

Rick Mullin, 2004 .

A SUSPENSEFUL ACT II FOR ROHNER: Custom synthesis leg of Dynamic Synthesis hopes to follow its transformation with growth

Rick Mullin, 2003 .

The ‘Million Dollar’ Interpretation

Rick Mullin, 2015 .

NEXT BIG THING AT INFORMEX: Contract chemistry and service firms rise to the challenge of the 'Life Sciences Age'

Rick Mullin, 2005 .

SOCMA AFTER INFORMEX: Trade association bolsters member services with a substitute for Responsible Care

Rick Mullin, 2005 .

MERCK ADVANCES LICENSING AGENDA

Rick Mullin, 2004 .

CRACKING THE SUSTAINABILITY CODE

Rick Mullin, 2004 .

GENERIC DRUGS Germany’s Fresenius will acquire heparin leader APP Pharmaceuticals

Rick Mullin, 2008 .

RIGHTSIZING PFIZER: The world’s largest drug company enters a new round of POSTMERGER CONSOLIDATION

Rick Mullin, 2010 .

G. Steven Burrill

Rick Mullin, 2013 .

Pfizer Settles Celebrex Lawsuit

Rick Mullin, 2013 .

First gene-edited babies born, scientist claimsFirst gene-edited babies born, scientist claims

Ryan Cross, Jean-François Tremblay, Rick Mullin, 2018 .

MERGERS Pfizer to enter ADHD market with acquisition of NextWave Pharmaceuticals

Rick Mullin, 2013 .

PFIZER MEETS ANALYSTS

Rick Mullin, 2008 .

GlaxO, Novartis Go Head-To-Head

Rick Mullin, 2005 .

ELLEN KULLMAN IS DUPONT’S NEW CEO: BUSINESS: Incoming chief executive will focus on expanding a transformed chemical giant

Rick Mullin, 2008 .

BIOTECH RIDES A BULL INTO 2004

Rick Mullin, 2004 .

The rise and fall of the U.S. CMO

Rick Mullin, 2018 .

CPHI SHOWCASES TRANSFORMATION

Rick Mullin, 2004 .

GILEAD BUILDS FOR SPEED: BIOPHARMACEUTICAL FIRM takes the next step in securing an early-stage manufacturing base

Rick Mullin, 2007 .

The chemistry’s new in black and blue

Rick Mullin, 2017 .

Recalibrating the clinic

Rick Mullin, 2005 .

BREAKING TRADITION IN IRELAND: Big shifts in the PHARMACEUTICAL INDUSTRY force change on a workhorse chemical manufacturing sector

Rick Mullin, 2010 .

Are You Paying To Be Served

Rick Mullin, 2005 .

BIOTECH FACES ITS PAST AND FUTURE

Rick Mullin, 2004 .

DRUG RESEARCH University of Texas clinic will partner with GlaxoSmithKline

Rick Mullin, 2007 .

CHINESE ADVANTAGE ROOTED IN THE U.S.: Aiming to offer the best, some Chinese ENTREPRENEURS base their companies in the U.S. but do R&D and production in China

Rick Mullin, 2008 .

GUARDING THE ENTERPRISE: DATA-LOSS PREVENTION emerges as a new line of defense for information technology

Rick Mullin, 2010 .

UPSWING AHEAD: An emerging biotech bonanza riveted contract manufacturers at INFORMEX

Rick Mullin, 2007 .

MEET THE ITALIANS: FIS rebounds from a big slump with a NEWFOUND DIRECTION in marketing

Rick Mullin, 2007 .

HIGHER TECHNOLOGY: The rebounding CUSTOM PHARMACEUTICAL chemical business pushes the high-tech envelope

Rick Mullin, 2007 .

AMGEN BUYS INTO TOP BIOTECH HUB

Rick Mullin, 2004 .

LILLY TO PAY BIG FOR IMCLONE

Rick Mullin, 2008 .

BOOKS: THE FINE LINEAn insider puts the details of the complex fine chemicals industry into HISTORICAL PERSPECTIVE

Rick Mullin, 2007 .

INSIGHTS: The Metropark DeskWhere CHEMISTRY REACHES beyond the world of science

Rick Mullin, 2006 .

CHALLENGES FOR MEDICINAL CHEMISTRY: ACS-sponsored forum explores ways to serve pharmaceutical companies' needs

Rick Mullin, 2003 .

Information Technology: Avantor sues IBM, citing problems with SAP software

Rick Mullin, 2013 .

EXELIXIS RESTRUCTURES: BIOTECH: Cancer drug firm shifts resources to development and cuts 40% of jobs

Rick Mullin, 2010 .

DRUG DISCOVERY Alnylam licenses RNAi technology to Takeda for Asian market

Rick Mullin, 2008 .

SOCMA BRINGS ITS MEMBERS TO TOWN: Small chemical producers get FACE TIME on Capitol Hill

Rick Mullin, 2009 .

LILLY TO ACQUIRE PARTNER ICOS

Rick Mullin, 2006 .

CUSTOM CHEMICALS INFORMEX DISPLAYS TOUGH TIMES

Michael Mccoy, Rick Mullin, 2004 .

PETER POLLAK: A VISIONARY in the fine chemicals industry claims a victory in a still-risky business

Rick Mullin, 2009 .

Tripos To Research Fellows In England

Rick Mullin, 2005 .

Fine Chemicals Firms Find Generics Niche

Rick Mullin, 2013 .

REALITY CHECK: Meeting looks at science, regulatory, and health care hurdles to PERSONALIZED MEDICINE

Rick Mullin, 2009 .

Picking Up The Pieces

Rick Mullin, 2003 .

DRUG MAJORS TALK TO WALL STREET

Rick Mullin, 2005 .

U.S. COURT REVIVES PRICE-FIXING CLAIMS: Reagan-era law gives non-U.S. plaintiffs access to stateside courts

Rick Mullin, 2003 .

Novartis opts to buy Selexys Pharma

Rick Mullin, 2016 .

Vetting Threats To Safe Drug Supplies

Rick Mullin, 2013 .

Pharmaceutical dealmaking hit a peak in 2018

Rick Mullin, 2019 .

Allergan targets nerves and the gut

Rick Mullin, 2017 .

AT 50, HOVIONE TAKES A BIG STEP: Portuguese fine chemicals firm TARGETS BIG PHARMA with a plant acquired from Pfizer

Rick Mullin, 2009 .

SOLUTIA TO KEEP PHARMA SERVICES

Rick Mullin, 2005 .

UCB SET TO BUY U.K. BIOTECH FIRM

Rick Mullin, 2004 .

HIGH-TECH PUSH FOR CUSTOM FIRMS

Ann Thayer, Lisa Jarvis, Rick Mullin, 2006 .

Breaking The Cycle Of Commoditization

Rick Mullin, 2004 .

SHOCKING DEVELOPMENTS: How scientific discoveries in the ROMANTIC ERA set diverging paths for faith and reason

Rick Mullin, 2009 .

Samsung, Takeda team for new biologics

Rick Mullin, 2017 .

UP FROM DESKTOPS

Rick Mullin, 2008 .

PFIZER TO BUY BIOTECH FIRM

Rick Mullin, 2004 .

INSIGHTS: CRACKING THE SUSTAINABILITY CODEChemists move to the front line as public concern shifts to products

Rick Mullin, 2004 .

Gilead to pay Merck in patent dispute

Rick Mullin, 2016 .

A DRUG DISCOVERY KNOWLEDGE GAP

Vivien Marx, Rick Mullin, 2004 .

RHODIA WILL EXIT CUSTOM SYNTHESIS

Rick Mullin, 2006 .

SNPE Refutes Charge Of Illegal Sales To Iraq

Rick Mullin, 2003 .

FINE CHEMICALS Saltigo, SAFC gear up for pharma on the West Coast

Rick Mullin, 2008 .

A research center at Rutgers fosters continuous tableting

Rick Mullin, 2019 .

SHARING DRUG DATA

Rick Mullin, 2005 .

THE CONSULTING NICHE

Rick Mullin, 2005 .

Global Version Of Responsible Care Launched

Rick Mullin, 2005 .

THE NEXT WAVE IN BIOPHARMACEUTICALS

Rick Mullin, 2005 .

Universities Visit The Business Model

Rick Mullin, 2013 .

Croda buys marine biology services firm

Rick Mullin, 2018 .

MOMENTUM BUILDS AGAINST BISPHENOL A: TOXICOLOGY: Move to eliminate chemical from some products begins

Susan Morrissey, Rick Mullin, 2008 .

Act 2 for chemical e-commerce

Rick Mullin, 2019 .

Open House: Fine chemicals producers respond enthusiastically to an INVITATION FROM NOVARTIS

Rick Mullin, 2010 .

Sanofi, AstraZeneca in respiratory deal

Rick Mullin, 2017 .

DRUG RESEARCHERS RELENT ON SOFTWARE

Rick Mullin, 2005 .

ISOCHEM EXPANDED: SNPE regroups its chemicals division as the dust settles in Toulouse, France

Rick Mullin, 2002 .

AstraZeneca To Overhaul Clinical Processes

Rick Mullin, 2005 .

DOWS EMOTIONAL PITCH: Eschewing facts and figures, a new AD CAMPAIGN shoots for the heart

Rick Mullin, 2006 .

WTO DRUG PACT BYPASSES PATENTS: Plan allows poor countries to obtain inexpensive generic medicines

Rick Mullin, 2003 .

TRIPOS BUILDS AN INFO-SCAFFOLD

Rick Mullin, 2004 .

Statistical Method Makes A Comeback

Rick Mullin, 2013 .

CAMBREX GETS DOWN TO FIGHTING WEIGHT

Rick Mullin, 2004 .

An Orphan Gets Help

Rick Mullin, 2014 .

ACS Award for Team Innovation

Rick Mullin, 2006 .

Buyer - And Seller - Beware

Rick Mullin, 2004 .

SAFE HAVENS: Custom chemical producers at Chemspec showcase PHARMA AND AGCHEM in a down year

Rick Mullin, 2009 .

Lilly and Purdue sign R&D agreement

Rick Mullin, 2017 .

Breaking down barriers

Rick Mullin, 2007 .

SEEKING AVENTIS: Novartis states its case in wake of France's support for Sanofi

Rick Mullin, 2004 .

R&D HEADS SHIFT AT BIG PHARMA: R&D MANAGEMENT: Pfizer and AstraZeneca get new research chiefs

Rick Mullin, 2010 .